Institutional owners may ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) recent US$25m market cap decline as longer-term profits stay in the green

By Yahoo! Finance | Jun 20, 2024 at 09:12 AM EST

Ownership research and analyst forecasts provide insights into stock opportunities. Pyxis Oncology, Inc. (NASDAQ: PYXS) is primarily owned by institutions, with key shareholders like Pfizer Inc. and hedge funds. Insights from shareholder types and analyst forecasts can help in understanding a stock's potential.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.